Text Size

Comparison of Frequency of Use of Optive and Systane

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00406510
First received: November 30, 2006
Last updated: May 30, 2007
Last verified: May 2007
History of Changes
  Purpose

The purpose of this study is subjectively compare duration of action between Optive and Systane.


Condition Intervention Phase
Dry Eye
 Drug: Optive, Systane
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind

Further study details as provided by Innovative Medical:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Males or females > 18 years old
  • Mild to moderate dry eye symptoms
  • Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
  • Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

  • Current use of topical cyclosporine
  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
  • Ocular surgery within the past 3 months,
  • Active ocular allergies
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00406510

Locations
United States, California
Private Practice
Azusa, California, United States, 91702
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Milton Hom, OD Private Practice
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00406510     History of Changes
Other Study ID Numbers: 5283
Study First Received: November 30, 2006
Last Updated: May 30, 2007
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 16, 2013